Ziccum
Pre-clinicalZiccum’s mass transfer drying system LaminarPace opens up new formulation possibilities for next-generation biologics and biomolecules. It dries liquid biopharmaceuticals and vaccines into thermostable particle-engineered dry powders with no heart stress or heat degradation.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $9.2M
About
Ziccum’s mass transfer drying system LaminarPace opens up new formulation possibilities for next-generation biologics and biomolecules. It dries liquid biopharmaceuticals and vaccines into thermostable particle-engineered dry powders with no heart stress or heat degradation.
Drug Delivery
Funding History
2Total raised:$9.2M
Grant$500KMar 15, 2022
IPO$8.7MMay 28, 2021